Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001021771-17-000073
Filing Date
2017-07-07
Accepted
2017-07-07 16:54:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 MARK WEINREB SCHEDULE 13D AMENDMENT NO. 2 mweinreb13da2.htm SC 13D/A 30956
2 STOCK OPTION AGREEMENT ex99_1.htm EX-99.1 28764
  Complete submission text file 0001021771-17-000073.txt   61073
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Subject) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86699 | Film No.: 17955710
SIC: 8090 Services-Misc Health & Allied Services, NEC

Mailing Address STEM CELL ASSURANCE, INC. 555 HERITAGE DRIVE JUPITER FL 33458
Business Address
Weinreb Mark (Filed by) CIK: 0001527212 (see all company filings)

Type: SC 13D/A